Cyber Cao, M.S., joined Vivo with extensive healthcare experience in China. Prior to joining Vivo, Cyber was the leader of Nycomed North Asia strategy and business development. He helped Nycomed refurbish its China business and played an integral role in its $417 MM acquisition of Techpool, a leading Chinese pharmaceutical player. Prior to Nycomed, Cyber was at McKinsey & Company where he worked with both multi-national and local pharmaceutical companies on corporate strategy. Mr. Cao received his M.S. in Pharmacy Administration and a B.S. in Pharmaceutics from Peking University.